Tourettes Syndrome
NEJM 363:2332-2338, Kurlan,R., 2010
Tourette's Syndrome
NEJM 345:1184-1192, Jankovic,J., 2001
Olanzapine Can Worsen Parkinsonism
Neurol 50:1183-1184, Jimenez-Jimenez,F.J.,et al, 1998
Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 50:1195-1196, Wolters,E.C.,et al, 1998
Drug-Induced Movement Disorders:An Overview
In Movement Dis in Neurol & Neuropsych, Blackwell Sci Publ, Boston, 2:21., Miller,L.G.&Jankovic,J., 1992
Treatment of Gilles de la Tourette's Syndrome:Experience in a Predominantly Adult Population
Neurol 37:1828-1833, Mesulam,M.M.&Peterson,R.C., 1987
Giant Invasive Prolactinomas
Am J Med 83:995-1002, Murphy,F.Y.,et al, 1987
Metoclopramide-Induced Neuroleptic Malignant Syndrome
Arch Int Med 147:1495-1497, Friedman,L.S.,et al, 1987
Extrapyramidal Reactions with Metoclopramide
BMJ 291:930-932, Bateman,D.N.,et al, 1985
Pimozide for Tourette's Disorder
Medical Letter 27:3-4, , 1985
Treatment of Tourette's Syndrome with R022-1913, A D-2-Receptor Antagonist
NEJM 311:989, Uhr,S.B.,et al, 1984
Extrapyramidal Side-Effects Of Metoclopramide
Lancet 2:1254-1255, Kataria,M.,et al, 1981
Drug Therapy of Tardive Dyskinesia
NEJM 296:257, Kobayashi,R.M., 1977